纳米颗粒从肺部空气腔快速转移到体内。
Rapid translocation of nanoparticles from the lung airspaces to the body.
机构信息
Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
出版信息
Nat Biotechnol. 2010 Dec;28(12):1300-3. doi: 10.1038/nbt.1696. Epub 2010 Nov 7.
Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in the lung remains poorly understood. In this study, a series of near-infrared (NIR) fluorescent nanoparticles were systematically varied in chemical composition, shape, size and surface charge, and their biodistribution and elimination were quantified in rat models after lung instillation. We demonstrate that nanoparticles with hydrodynamic diameter (HD) less than ≈34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes. Nanoparticles of HD < 6 nm can traffic rapidly from the lungs to lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys. We discuss the importance of these findings for drug delivery, air pollution and carcinogenesis.
纳米级颗粒在肺部药物输送方面显示出巨大的应用潜力,但这些颗粒在肺部沉积后的行为仍未被充分了解。在本研究中,我们系统性地改变了一系列近红外(NIR)荧光纳米颗粒的化学成分、形状、尺寸和表面电荷,通过对肺部滴注后的大鼠模型进行定量分析,研究了其体内分布和消除情况。研究结果表明,直径小于约 34nm 且带负电荷的纳米颗粒能够迅速从肺部转移至纵隔淋巴结。直径小于 6nm 的纳米颗粒可以快速从肺部转移至淋巴结和血液,然后被肾脏清除。我们讨论了这些发现对于药物输送、空气污染和致癌作用的重要性。